ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Efficacy and Safety Assessment of T4090 Ophthalmic Solution Versus Rhopressa® Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension

ClinicalTrials.gov ID: NCT06394973

Public ClinicalTrials.gov record NCT06394973. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 10:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy and Safety Assessment of T4090 Ophthalmic Solution (Preservative-free Kinezodianone R HCl 0.2% or 0.3%) Versus Rhopressa® Ophthalmic Solution (Preserved Netarsudil 0.02%) in Patients With Open-angle Glaucoma or Ocular Hypertension

Study identification

NCT ID
NCT06394973
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Laboratoires Thea
Industry
Enrollment
161 participants

Conditions and interventions

Interventions

  • Rhopressa® Drug
  • T4090 0.2% Drug
  • T4090 0.3% Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 4, 2024
Primary completion
Nov 20, 2024
Completion
Nov 20, 2024
Last update posted
Jan 1, 2026

2024

United States locations

U.S. sites
24
U.S. states
10
U.S. cities
22
Facility City State ZIP Site status
Arizona Advanced Eye Research Institute Glendale Arizona 85306
Global Research Management, Inc. Glendale California 91204
United Medical Research Institute Inglewood California 90301
Eye Research Foundation Newport Beach California 92663
Visionary Research Institute Newport Beach California 92663
North Bay Eye Associates Petaluma California 94954
Sacramento Eye Consultants, A Medical Corporation Sacramento California 95815
Wolstan and Goldberg Eye Associates Torrance California 90505
Segal Drug Trials, Inc Delray Beach Florida 33484
East Coast Institute for Research, LLC Jacksonville Florida 32256
Shettle Eye Research, Inc. Largo Florida 33773
Mild Florida Eye Center Mt. Dora Florida 32757
Coastal Research Associates, LLC Roswell Georgia 30076
Seidenberg Protzko Eye Associates Havre de Grace Maryland 21078
Alterman, Modi and Wolter Ophthalmic Surgeons Poughkeepsie New York 12603
James D. Branch, MD Winston-Salem North Carolina 27101
Total Eye Care, PA Memphis Tennessee 38119
Keystone Research Austin Texas 78731
Glaucoma Associates of Texas Dallas Texas 75231
Houston Eye Associates Houston Texas 53719
Houston Eye Associates Houston Texas 77008
DCT-Shah Research, LLC sba Discovery Clinical Trials Mission Texas 78572
Emerson Clinical Research Institute Falls Church Virginia 22046
Piedmont Eye Center Lynchburg Virginia 24502

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06394973, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 1, 2026 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06394973 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →